Sacral Neuromodulation Market Is Expected To Reach USD 1.85 Billion By 2032.
Market Overview: In 2022, the global sacral Neuromodulation market was valued at USD 1.03 Billion and is projected to reach USD 1.85 Billion by 2032, with a compound annual growth rate (CAGR) of 6.8% during the forecast period. The market growth is primarily attributed to the increasing prevalence of Overactive Bladder Syndrome (OAB), fecal incontinence, and chronic pelvic discomfort. Approximately 1 in 6 adults experience OAB symptoms at some point in their lives, as reported by the International Continence Society, contributing to a rise in sacral neuromodulation treatments globally.
The aging population is a significant factor contributing to the surge in OAB and fecal incontinence rates. Age-related bladder capacity reductions lead to uncontrollable contractions, resulting in incontinence. The United Nations Population Division predicts that by 2050, there will be 2.1 billion individuals aged 60 or older globally, further boosting the demand for sacral neuromodulation devices.
Get a sample copy of the Sacral Neuromodulation Market report: https://www.reportsanddata.com/download-free-sample/1487
Technological advancements in sacral neuromodulation devices also drive market growth. Manufacturers are focusing on developing sophisticated, patient-friendly devices for enhanced effectiveness. For example, Medtronic plc's InterStim Mini neurostimulator, designed for sacral neuromodulation therapy, provides increased patient comfort and long-term symptom relief for OAB and fecal incontinence. Such innovations in device design are anticipated to improve patient compliance and fuel market revenue growth.
Additionally, favorable reimbursement practices and the escalating cost of healthcare contribute to market growth. Payment rules favoring sacral neuromodulation therapies are implemented by numerous countries, expanding patient access. For instance, the Centers for Medicare & Medicaid Services (CMS) in the United States reimburse sacral neuromodulation operations for fecal and urine incontinence treatments. The increasing healthcare costs, especially in developing countries, are expected to drive the adoption of sacral neuromodulation procedures and further boost market revenue.
However, challenges to market growth include the high cost of sacral neuromodulation devices and a lack of awareness about the therapy. Affordability issues in underdeveloped countries, coupled with a lack of knowledge in rural areas, are hindering the adoption of sacral neuromodulation therapy.
Government Regulations for Sacral Neuromodulation Market: The U.S. Food and Drug Administration (FDA) has approved sacral neuromodulation for various conditions, including urinary urge incontinence, non-obstructive urinary retention, fecal incontinence, and chronic pelvic pain syndrome. Manufacturers must demonstrate the safety and effectiveness of devices before marketing them in the United States.
Medicare Part B covers the cost of sacral neuromodulation therapy for eligible patients, as determined by specific criteria, including failed alternative treatments and no contraindications to the procedure.
The Center for Medicare and Medicaid Services has established coverage rules, including indications for use, patient eligibility criteria, and coding requirements.
Manufacturers are required to register their devices with the FDA before marketing them in the United States, as per the U.S. Department of Health and Human Services.
The American Society of Anesthesiologists recommends preoperative counseling for patients undergoing sacral neuromodulation therapy to discuss potential risks and benefits.
Market Segmentation: The sacral neuromodulation market is segmented based on product type, application, end-use, and region:
Product Type:
- Rechargeable
- Non-rechargeable
Application:
- Urinary Incontinence
- Fecal Incontinence
- Chronic Pain
End-Use:
- Hospitals
- Ambulatory Surgery Centers
- Clinics
- Others (including long-term care facilities and home healthcare settings)
Regional Outlook:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Companies:
- Medtronic plc
- Axonics Modulation Technologies Inc.
- Nuvectra Corporation
- StimWave Technologies Inc.
- BlueWind Medical
- Synapse Biomedical Inc.
Competitive Landscape: The sacral neuromodulation market features key players such as Medtronic plc, Axonics Modulation Technologies Inc., Nuvectra Corporation, StimWave Technologies Inc., BlueWind Medical, and Synapse Biomedical Inc. These companies engage in strategic developments, including product launches and acquisitions, to enhance their market presence.
Strategic Developments:
- Axonics Modulation Technologies launched the r-SNM System, its second-generation implantable neurostimulator, with improved battery life and smaller size.
- Medtronic plc acquired Stimgenics, LLC, to expand its pain management portfolio with a novel spinal cord stimulation (SCS) waveform.
- Nuvectra Corporation formed a strategic partnership with Neurogress to develop next-generation neuromodulation devices controlled by a brain-computer interface (BCI).
- StimWave Technologies received FDA clearance for its wireless neuromodulation system for chronic pain treatment.
- BlueWind Medical completed a Series C funding round, raising $15 million for the development of its miniature neuromodulation device.
Explore Trending Reports:
Translucent Concrete Market-https://www.reportsanddata.com/report-detail/translucent-concrete-market
Cellulose Acetate Market-https://www.reportsanddata.com/report-detail/cellulose-acetate-market
Flotation Reagents Market-https://www.reportsanddata.com/report-detail/flotation-reagents-market
Cyclopentane Market-https://www.reportsanddata.com/report-detail/cyclopentane-market
Styrene Butadiene Rubber Market-https://www.reportsanddata.com/report-detail/styrene-butadiene-rubber-sbr-market
Polyphenylene Sulphide (PPS) Film Market-https://www.reportsanddata.com/report-detail/polyphenylene-sulphide-pps-film-market
Sintered Steel Market-https://www.reportsanddata.com/report-detail/sintered-steel-market
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/1487
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian